FDA Accepts for Priority Review the Supplemental New Drug Application for Merck’s PREVYMIS for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk Read more
Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck Read more
Roche expands collaboration with Janssen to advance personalised healthcare through companion diagnostics Read more
Vial Partners with Egnyte to Integrate Life Sciences’ eTMF Solution into Their Clinical Trial Platform Read more
IntelGenx Announces Research Collaboration with Renowned Neurologist to Evaluate Montelukast VersaFilm for the Treatment of Parkinson’s Disease Read more
FDA Grants Regenerative Medicine Advanced Therapy (Rmat) Designation for Rexlemestrocel-L in Chronic Low Back Pain Read more
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes Read more
EYLEA (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA Read more